Crossmark

Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration

Crossref DOI link: https://doi.org/10.1186/s40478-018-0649-3

Published Online: 2019-01-09

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ashton, Nicholas J.

Leuzy, Antoine

Lim, Yau Mun

Troakes, Claire

Hortobágyi, Tibor

Höglund, Kina

Aarsland, Dag

Lovestone, Simon

Schöll, Michael

Blennow, Kaj

Zetterberg, Henrik

Hye, Abdul
Funding

Funding for this research was provided by:

Marianne and Marcus Wallenberg Foundation (N/A)
License Information

Text and Data Mining valid from 2019-01-09
More Information

Article History

Received: 11 December 2018

Accepted: 11 December 2018

First Online: 9 January 2019

Competing interests

: KB and HZ are co-founders of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg. KB has served as a consultant or at advisory boards for Alzheon, Eli Lilly, Fujirebio Europe, IBL International, Novartis and Roche Diagnostics. HZ has served at advisory boards of Eli Lilly and Roche Diagnostics and has received travel support from TEVA. SL is an employee of Johnson and Johnson.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below